Abbott, Myriad to work jointly on drug development

04/12/2006 | Chicago Tribune (tiered subscription model)

Abbott Laboratories and Myriad Genetics are joining forces to allow the drugmaker to draw on Myriad's genetics and other drug-discovery technologies to produce novel products. Under the pact, Myriad will work to identify the genetic bases of diseases so Abbott can identify targets for drugs it might want to develop.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY